首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

2024435

高通量篩檢市場報告：按技術、產品和服務、應用、最終用戶和地區分類（2026-2034 年）

High-throughput Screening Market Report by Technology, Products and Services, Applications, End User, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年，全球高通量篩檢市場規模達291億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到527億美元，2026年至2034年的複合年成長率（CAGR）為6.63%。市場成長的主要促進因素包括：3D細胞培養模型的日益普及、對個人化醫療篩檢檢測需求的成長以及基於CRISPR的篩檢技術的不斷擴展應用。

高通量篩檢市場的發展趨勢：

高通量篩選設施增加

開發用於治療各種危及生命的疾病的新藥是推動市場成長的主要動力。此外，高通量篩檢( HTS) 設施數量的不斷成長也推高了近期 HTS 市場的價格。這些中心的主要優勢之一是促進研究人員、科學家和其他利害關係人之間的知識共用。例如，哥倫比亞基因組中心為哥倫比亞大學整個研究社區的研究人員提供高品質的分子篩檢服務。同樣，「歐盟開放篩選 (EU-open-screen)」是美國國立衛生研究院 (NIH) 計畫的歐洲版本，為所有從事化學生物學的歐洲公司提供開放取用途徑。高通量篩檢(HTS) 中心之間的合作旨在提供有關藥物、標靶或整個過程的寶貴資訊。因此，開放取用為知識共用提供了一個更好的平台，並有助於加速藥物篩檢過程。這很可能在未來幾年推動 HTS 市場佔有率的擴大。

新型分子開發拓展

各種感染疾病的蔓延推動了新分子和疫苗的研發，為高通量篩檢市場帶來了光明前景。此外，製藥生產過程中對各種藥物和分子進行準確快速篩檢的需求日益成長，也促進了自動化高通量篩檢技術的應用。許多製藥和生物技術公司也擴大採用高通量篩檢方法，因為該方法具有高靈敏度、自動化、樣品用量少、低背景訊號檢測能力等諸多優勢，從而推動了高通量篩檢市場的需求成長。根據美國國會預算辦公室發布的數據，2021年的一項調查顯示，2020年全球製藥業在研發方面的支出接近2,000億美元，較2019年的8,300萬美元大幅成長。同樣，丹納赫公司2021年的研發投資金額為17.4億美元，高於2020年的13.4億美元。此外，Bio-Rad Laboratories公司2021年的研發投資金額為8.796億美元，高於2020年的8.03億美元。企業研發投入的增加進一步提升了其在高通量篩檢檢測中引入創新技術的能力，從而推動了市場成長。

技術進步

近年來，在機器人、自動化、數據分析和小型化等領域的持續創新推動下，高通量篩檢(HTS) 技術取得了顯著進展。此外，自動化和機器人技術的進步顯著提高了 HTS 工作流程的速度和效率。自動化液體處理系統、盤式分析儀和機器人平台現在能夠以高精度和高通量執行重複性任務，從而減少了人工干預的需求。此外，許多領先的生物技術公司正在投資研發活動，以推出改進的 HTS 技術，預計這將推動高通量篩檢市場的收入成長。例如，2024 年 2 月，生命科學分析技術領域的全球領導者 SCIEX 在 SLAS 2024 上發布了其 Echo MS+ 系統。該系統結合了專有的聲波噴射質譜技術和開放式連接埠介面 (OPI) 取樣，並融合了 SCIEX ZenoTOF 7600 或 Triple Quad 6500+ 系統的強大功能，可透過各種穩健的高通量篩檢工作流程提供準確的定性和定量結果。

市場結構
大公司
主要公司簡介
- Agilent Technologies Inc.
- Aurora Biomed Inc.
- Axxam SpA
- Beckman Coulter Inc.（Danaher Corporation）
- Bio-RAD Laboratories Inc.
- Charles River Laboratories International Inc.
- Corning Incorporated
- Luminex Corporation（DiaSorin）
- Perkinelmer Inc.
- Sygnature Discovery
- Tecan Group Ltd.
- Thermo Fisher Scientific

簡介目錄圖表

Product Code: SR112026A5704

The global high-throughput screening market size reached USD 29.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 52.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.63% during 2026-2034. The increased adoption of 3D cell culture models, growing demand for personalized medicine screening assays, and rising application of CRISPR-based screening techniques are some of the key factors driving the market growth.

High-Throughput Screening Market Analysis:

Major Market Drivers: The increasing utilization of HTS for minimizing the time required for manufacturing a drug is primarily driving the growth of the market. Furthermore, the development of new medicines for treating various life-threatening diseases is also catalyzing the demand for HTS techniques.

Key Market Trends: Integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) with high-throughput screening to facilitate automation and fast data processing is one of the significant trends, augmenting the growth of the market.

Geographical Landscape: The high-throughput screening market forecast report has provided a detailed breakup and analysis of the market based on the region. This includes North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. North America is expected to hold a significant market share in the high-throughput screening market owing to factors such as the increasing adoption of high-throughput screening, rising research and development expenditure, and the growing advances in combinatorial chemistry and the field of genomics.

Competitive Landscape: Some of the leading high-throughput screening market companies include Agilent Technologies Inc., Aurora Biomed Inc., Axxam S.p.A, Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Charles River Laboratories International Inc. Corning Incorporated, Luminex Corporation (DiaSorin), Perkinelmer Inc., Sygnature Discovery, Tecan Group Ltd., and Thermo Fisher Scientific, among many others.

Challenges and Opportunities: Challenges in the high-throughput screening market include data management complexities and the need for more physiologically relevant assay models, while opportunities lie in advancing technologies like automation, artificial intelligence, and organ-on-a-chip systems for more efficient and predictive screening processes.

High-Throughput Screening Market Trends:

Increasing Number of HTS Facilities

The development of new medicines for treating various life-threatening diseases is primarily driving the growth of the market. Furthermore, the rise in the utilization of HTS for minimizing the time required for manufacturing a drug is also contributing to the market growth. In addition to this, the escalating number of high-throughput screening (HTS) facilities is also catalyzing the high-throughput screening market's recent prices. One of the significant advantages of these centers is knowledge sharing among investigators, scientists, researchers, etc. For instance, the Columbia Genome Center offers high-quality molecular screening services for investigators throughout the Columbia University research community. Also, the European counterpart of the National Institutes of Health (NIH) program, known as EU-open-screen, provides open access to all European companies engaged in chemical biology. The association of high-throughput screening (HTS) centers is intended to provide useful information about the drug or target or the entire process. Thus, open access provides a better platform for knowledge sharing and can help accelerate the drug development process, which may drive the high-throughput screening market share in the coming years.

Rising Development of Novel Molecules

The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is creating a positive outlook for the high-throughput screening market. Moreover, the escalating need for precise and quick screening of various drugs and molecules during the manufacturing of a drug is resulting in an increased adoption of automated high-throughput screening techniques. Furthermore, various pharmaceutical and biologic firms are increasingly adopting high-throughput screening methods on account of their various advantages, such as high sensitivity, automation, minimization of the sample, and the ability to detect low background signals, which is bolstering the high-throughput screening market demand. According to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally, compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1.74 billion in its research and development in 2021, as compared to US$ 1.34 billion in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the increasing investment in research and development by the companies further increases their capabilities to adopt innovative technologies in high throughput screening assays, thereby increasing the market growth.

Technological Advancements

High-throughput screening (HTS) techniques have seen significant advancements in recent years, driven by the continuous innovations in robotics, automation, data analysis, and miniaturization. Moreover, advances in automation and robotics are extensively increasing the speed and efficiency of HTS workflows. Automated liquid handling systems, plate readers, and robotic platforms can now perform repetitive tasks with high precision and throughput, reducing the need for manual intervention. Additionally, various leading biotech companies are also investing in research and development activities to introduce improved HTS methods which are anticipated to propel the high-throughput screening market revenue. For instance, in February 2024, SCIEX, a global leader in life science analytical technologies, launched the Echo MS+ system at SLAS 2024. The system couples proprietary Acoustic Ejection Mass Spectrometry technology and Open Port Interface (OPI) sampling with the capabilities of either the SCIEX ZenoTOF 7600 or Triple Quad 6500+ system to deliver precise qualitative and quantitative results through an expanded panel of robust high-throughput screening workflows.

Global High-Throughput Screening Market Segmentation:

This report provides an analysis of the key trends in each segment of the global high-throughput screening market report, along with forecasts at the global, regional, and country levels from 2026-2034. The report categorizes the market based on technology, products and services, applications, and end user.

Breakup by Technology:

Ultra-High-Throughput Screening
Cell-Based Assays
Lab-on-a-Chip
Label-Free Technology

The high-throughput screening market overview indicates that cell-based assays are increasingly being used by various pharmaceutical and biotech companies. Cell-based assays in high-throughput screening utilize live cells as the biological readout for compound testing, enabling the evaluation of drug candidates' effects on cellular function, viability, and phenotype in a high-throughput manner, often employed in drug discovery and toxicity screening. Fluorometric imaging plate reader assays have become the most used cell-based assays owing to visible results and their ability to test with the smallest of volumes. Besides this, ultra-high-throughput screening is the latest technology and is used for increased output in less time. A majority of companies are in a transition phase from 2D-cell cultures to 3D-cell cultures as 3D cells show more lifelike properties while testing in the natural environment and other cell-related manipulations, aided for drug design and discovery.

Breakup by Products and Services:

Instruments
Reagents and Kits
Services

The high-throughput screening market report has provided a detailed breakup and analysis of the market based on the products and services. This includes instruments, reagents and kits, and services.

High-throughput screening relies on specialized instruments, such as automated liquid handlers, plate readers, and robotic platforms. These instruments enable the rapid handling, dispensing, and analysis of samples in microplate formats, thereby increasing the efficiency and throughput of screening experiments. Whereas reagents and kits that are used in high-throughput screening include compound libraries, biochemical assays, and detection reagents such as fluorescent probes or enzyme substrates. These are optimized for compatibility with automated systems and miniaturized assay formats, allowing for the screening of large compound libraries against specific biological targets or pathways.

Breakup by Applications:

Target Identification and Validation
Primary and Secondary Screening
Toxicology Assessment
Others

Target identification and validation involves identifying and validating molecular targets (such as proteins, genes, or cellular pathways) that are implicated in a disease or biological process. Through various methods, including genomics, proteomics, and bioinformatics, potential targets are identified and then validated to ensure their relevance and draggability for further investigation. Whereas in primary and secondary screening large libraries of compounds are tested against a specific target or biological assay to identify initial hits that show activity or modulation. This method involves a more detailed characterization of hit compounds to confirm their activity, selectivity, and potency. Primary and secondary screening typically includes dose-response studies, counter-screens, and secondary assays to validate hits and prioritize them for lead optimization and preclinical development.

Breakup by End User:

Pharmaceutical and Biotechnology Firms
Academic and Government Institutes
Contract Research Organizations
Others

According to high-throughput screening market statistics, the spending on research and development (R&D) by both pharmaceutical companies and government organizations has been increasing recently, which is anticipated to drive market growth over the forecast period. For instance, Danaher Corporation, a leading global life sciences and diagnostics innovator, invested US$ 1.74 billion in its research and development in 2021, as compared to US$ 1.34 billion in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the huge investment by pharmaceuticals, biotech firms, and government institutions will continue to drive the market growth.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is expected to hold a significant market share in the high-throughput screening market owing to various factors such as the increasing adoption of high-throughput screening, rising research and development expenditure, and the growing advances in combinatorial chemistry and the field of genomics. In addition to this, the presence of prominent market players in the region is also positively impacting the high-throughput screening market outlook. For instance, in August 2021, Becton, Dickinson, and Company launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the United States. This launch made BD Onclarity HPV Assay with extended genotyping for the BD COR System available to the high-throughput labs for processing most cervical cancer screening specimens in the United States with persistent infection with human papillomavirus (HPV).

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.
Aurora Biomed Inc.
Axxam S.p.A
Beckman Coulter Inc. (Danaher Corporation)
Bio-RAD Laboratories Inc.
Charles River Laboratories International Inc.
Corning Incorporated
Luminex Corporation (DiaSorin)
Perkinelmer Inc.
Sygnature Discovery
Tecan Group Ltd
Thermo Fisher Scientific

Key Questions Answered in This Report:

How has the global high-throughput screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global high-throughput screening market?
What are the key regional markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the products and services?
What is the breakup of the market based on the applications?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global high-throughput screening market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global High-throughput Screening Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Technology

6.1 Ultra-High-Throughput Screening
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Cell-Based Assays
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Lab-on-a-Chip
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Label-Free Technology
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Products and Services

7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Reagents and Kits
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Services
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Applications

8.1 Target Identification and Validation
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Primary and Secondary Screening
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Toxicology Assessment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical and Biotechnology Firms
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Academic and Government Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Contract Research Organizations
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Aurora Biomed Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Axxam S.p.A
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Beckman Coulter Inc. (Danaher Corporation)
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 SWOT Analysis
- 15.3.5 Bio-RAD Laboratories Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Charles River Laboratories International Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Corning Incorporated
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Luminex Corporation (DiaSorin)
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 SWOT Analysis
- 15.3.9 Perkinelmer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sygnature Discovery
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Tecan Group Ltd.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: High-throughput Screening Market: Major Drivers and Challenges
Figure 2: Global: High-throughput Screening Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: High-throughput Screening Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: High-throughput Screening Market: Breakup by Technology (in %), 2025
Figure 5: Global: High-throughput Screening Market: Breakup by Products and Services (in %), 2025
Figure 6: Global: High-throughput Screening Market: Breakup by Applications (in %), 2025
Figure 7: Global: High-throughput Screening Market: Breakup by End User (in %), 2025
Figure 8: Global: High-throughput Screening Market: Breakup by Region (in %), 2025
Figure 9: Global: High-throughput Screening (Ultra-High-Throughput Screening) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: High-throughput Screening (Ultra-High-Throughput Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: High-throughput Screening (Cell-Based Assays) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: High-throughput Screening (Cell-Based Assays) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: High-throughput Screening (Lab-on-a-Chip) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: High-throughput Screening (Lab-on-a-Chip) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: High-throughput Screening (Label-Free Technology) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: High-throughput Screening (Label-Free Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: High-throughput Screening (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: High-throughput Screening (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: High-throughput Screening (Reagents and Kits) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: High-throughput Screening (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: High-throughput Screening (Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: High-throughput Screening (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: High-throughput Screening (Target Identification and Validation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: High-throughput Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: High-throughput Screening (Primary and Secondary Screening) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: High-throughput Screening (Primary and Secondary Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: High-throughput Screening (Toxicology Assessment) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: High-throughput Screening (Toxicology Assessment) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: High-throughput Screening (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: High-throughput Screening (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: High-throughput Screening (Pharmaceutical and Biotechnology Firms) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: High-throughput Screening (Pharmaceutical and Biotechnology Firms) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: High-throughput Screening (Academic and Government Institutes) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: High-throughput Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: High-throughput Screening (Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: High-throughput Screening (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: High-throughput Screening (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: High-throughput Screening (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: North America: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: North America: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: United States: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: United States: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Canada: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Canada: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Asia-Pacific: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Asia-Pacific: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: China: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: China: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Japan: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Japan: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: India: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: India: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: South Korea: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: South Korea: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: Australia: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: Australia: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Indonesia: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Indonesia: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Others: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Others: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Europe: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Europe: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Germany: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Germany: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: France: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: France: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: United Kingdom: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: United Kingdom: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Italy: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Italy: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Spain: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Spain: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Russia: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Russia: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Others: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Others: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Latin America: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Latin America: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Brazil: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Brazil: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Mexico: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: Mexico: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: Others: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: Others: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Middle East and Africa: High-throughput Screening Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Middle East and Africa: High-throughput Screening Market: Breakup by Country (in %), 2025
Figure 87: Middle East and Africa: High-throughput Screening Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 88: Global: High-throughput Screening Industry: SWOT Analysis
Figure 89: Global: High-throughput Screening Industry: Value Chain Analysis
Figure 90: Global: High-throughput Screening Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: High-throughput Screening Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: High-throughput Screening Market Forecast: Breakup by Technology (in Million USD), 2026-2034
Table 3: Global: High-throughput Screening Market Forecast: Breakup by Products and Services (in Million USD), 2026-2034
Table 4: Global: High-throughput Screening Market Forecast: Breakup by Applications (in Million USD), 2026-2034
Table 5: Global: High-throughput Screening Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 6: Global: High-throughput Screening Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 7: Global: High-throughput Screening Market: Competitive Structure
Table 8: Global: High-throughput Screening Market: Key Players

02-2729-4219

+886-2-2729-4219